ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 7.76
+0.81 (11.65%)
Mar 5, 2026, 4:29 PM GMT
ImmuPharma Employees
ImmuPharma had 6 employees as of December 31, 2024. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-655.75K GBP
Market Cap
34.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Poolbeg Pharma | 16 |
| Arecor Therapeutics | 44 |
| hVIVO | 301 |
| Aptamer Group | 31 |
| Faron Pharmaceuticals Oy | 32 |
| Hemogenyx Pharmaceuticals | 16 |
| SkinBioTherapeutics | 41 |
| Sareum Holdings | 5 |
ImmuPharma News
- 17 days ago - AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West - The Armchair Trader
- 3 months ago - FTSE Flat as Wall Street Gains Fail to Inspire - Investomania
- 3 months ago - AIM Market Roundup: Trellus Health, Great Western Mining, EMV Capital - The Armchair Trader
- 6 months ago - AIM Market Roundup: ImmuPharma, Rockfire Resources, Likewise - The Armchair Trader
- 6 months ago - AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals - The Armchair Trader
- 6 months ago - AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien - The Armchair Trader
- 7 months ago - AIM Market Roundup: Catenai, Europa Oil & Gas, Faron Pharma - The Armchair Trader
- 7 months ago - FTSE Rises as Investors Eye Tariff Deadline - Investomania